MIRIAM HALAZON: Open Payments
NPI 1568878023 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 49 payments from 15 companies in 2025. Trend: 2023 $1,025 · 2024 $428 · 2025 $1,118
Food & beverage: $1,029Education: $89
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $169 |
| Merck Sharp & Dohme LLC | 7 | $139 |
| Alnylam Pharmaceuticals Inc. | 4 | $131 |
| BridgeBio Pharma, Inc. | 4 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $119 |
| Actelion Pharmaceuticals US, Inc. | 1 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Amgen Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: VYNDAQEL, AMVUTTRA, VERQUVO, Attruby, Kerendia, OPSUMIT, LEQVIO, JARDIANCE.
Industry payments across CO — which companies pay providers there.
